Programa científico ISAD 2012


Published on

Más información en

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Programa científico ISAD 2012

  1. 1. ISAD 2012 th th 18 – 20 April 2012, Royal College of Physicians, London, UKDay 1: Wednesday, 18th April 201207:30 Registration opens in lobby of RCP08:30 – SYMPOSIUM 1 SYMPOSIUM 2 SYMPOSIUM 310:30 Council Chamber Linacre and Sloane Room Wolfson Theatre Hearts and Minds: the links Bipolar Disorder and Brain Stimulation Methods for between co morbid Substance Use Disorder Treating Depression – Critical depression and heart Comorbidity: New Findings Review of Latest Clinical disease and best treatment Findings and New Session Chair: Roger Weiss Technological Advances Session Chair: André Tylee (Harvard Medical School) (King’s College London) Session Chair: Mark George (Medical University of South Carolina) [S1.1] [S2.1] [S3.1]08:30 Early findings from the Integrated Group Therapy for Whats the latest with the UPBEAT Cohort Bipolar Disorder and oldest? ECT advances. André Tylee (King’s College Substance Abuse Harold Sackeim (Columbia London) Roger Weiss (Harvard Medical University) School) [S1.2] [S2.2] [S3.2]09:00 Treatment of depression in Sleep difficulties in Bipolar New advances with heart disease Disorder and SUD transcranial magnetic Chris Dickens Margaret Griffin (Harvard Medical stimulation (Peninsula College of Medicine School) Klaus Ebmeier (University of and Dentistry) Oxford) [S1.3] [S2.3] [S3.3]09:30 Determinants of Optimizing pharmacotherapy: Vagus Nerve Stimulation depression in cardiac Bipolar and Alcoholism Michael Trimble (Queen’s Square patients Ihsan Salloum (University of Andrew Steptoe (University Miami) College London) [S1.4] [S2.4] [S3.4]10:00 Final analyses of the 2-Year Tx Outcome: Bipolar v. Deep Brain Stimulation MIND-IT study Depressed Alcoholics Thomas Schlaepfer (John Hopkins Peter de Jonge Conor Farren (St. Patrick’s Hospital) (UMCG University of University) Groningen)10:30 –11:00 Tea/Coffee Break, Exhibition and Poster Viewing11:00 – Plenary Session 1 – Wolfson Theatre12:00 Chair: Bernard Lerer (Hadassah-Hebrew University Medical Center) Affective disorders – new economic realities Martin Knapp (Kings College London, Institute of Psychiatry)12:00 – Lunch Break, Exhibition and Poster Viewing13:30 1
  2. 2. 12:15 – Lundbeck Lunchtime Satellite Symposium13:25 “Recent Advances in the Management of Bipolar Disorder” Welcome and Introduction Allan Young, Professor of Psychiatry, Imperial College London, UK Pharmacological Basis for the Clinical Effects of Antipsychotics Andrea Fagiolini, Associate Professor of Psychiatry, University of Siena, Italy Asenapine in the Treatment of Bipolar Disorder I, Acute and Sustained Effects Heinz Grunze, Professor of Clinical Psychiatry, Newcastle University, UK Summary & Closing Remarks Allan Young, Professor of Psychiatry, Imperial College London, UK13:30 – SYMPOSIUM 4 SYMPOSIUM 5 SYMPOSIUM 615:30 Council Chamber Wolfson Theatre Linacre and Sloane Room Mood Disorders and Diet and Nutrition: New Psychopharmacology of Somatic Comorbidity: From Opportunities for the Affective Disorders: Is There a Associations to Prevention and Treatment of Future? Mechanisms Moody and Anxiety Disorders Session Chair: Bernard Lerer Session Chair: Martin Preisig Session Chair: Felice Jacka (Hadassah-Hebrew University (University of Lausanne) (Deakin University) Medical Center) [S4.1] [S5.1] [S6.1]13:30 Mortality of 406 patients Diet and Nutrition: New Generic SSRIs: The End of with mood disorders over opportunities for the History? prevention and treatment of 50 years after admission Phil Cowen (University of Oxford) mood and anxiety disorders Jules Angst (University of across the lifecourse Zurich) Felice Jacka (Deakin University) [S4.2] [S5.2] [S6.2]14:00 Mood disorders, Mediterranean Diet, trans fatty Hormonal Therapies and cardiovascular risk factors acids and depression. The SUN Antidepressant Development and inflammatory markers: Project Bernard Lerer (Hadassah-Hebrew results of a population- Almudena Sánchez-Villegas University Medical Center) based survery (University of Las Palmas de Gran Jennifer Glaus (University Canaria) Hospital Center and University of Lausanne) [S4.3] [S5.3] [S6.3]14:30 Bone quality in mood Dietary patterns and Pharmacogenetics and disorders depression in Japan Antidepressant Treatment Lana Williams (Deakin Akiko Nanri (International Clinical Julio Licinio (Australian National University) Research Center) University) [S4.4] [S5.4] [S6.4]15:00 Depression and Obesity Nutritional supplements for Neural plasticity & Novel Mood Julie Pasco (University of the treatment of mood Disorder Therapies Melbourne) disorders Husseini Manji (Johnson & Jerome Sarris (University of Johnson Pharmaceuticals) Melbourne)15:30 –16:00 Tea/Coffee Break, Exhibition and Poster Viewing 2
  3. 3. ORAL PRESENTATION ORAL PRESENTATION ORAL PRESENTATION16:00 – SESSION 1 SESSION 2 SESSION 317:30 Linacre and Sloane Room Wolfson Theatre Council Chamber Session Chair: Elliott Session Chair: Ray Lam Session 3: Anthony Cleare Richelson (The Mayo Clinic) (University of British Columbia) (Institute of Psychiatry, UK) [O1.1] [O2.1] [O3.1] Neurophysiological Physical exercise as an Suicide increased in untreated predictors of non-response adjuvant therapy for young individuals in Sweden16:00 to rTMS in Depression depression after "Black BOX" warnings for Martijn Arns (Brainclinics) Jorge Mota-Pereira "suicidality" as an adverse effect of antidepressants Göran Isacsson [O1.2] [O2.2] [O3.2] The Relationship Between Aggregation of mood spectrum Computerised CBT for older Brain Oscillatory Activity disorders in clinical and adults with depression and and Therapeutic population based families comorbid cardiovascular16:15 Effectiveness of Caroline Vandeleur disease -a randomised, Transcranial Magnetic double-blind, placebo Stimulation in the controlled trial Treatment of MDD Nick Glozier (Sydney Medical Andrew Leuchter (UCL) School) [O1.3] [O2.3] [O3.3] Relapse rates following a Co-occurring psychopathology Epilepsy and major successful course of in parents with recurrent depression, bipolar disorder, electroconvulsive therapy depression and risk to and suicide attempt: Evidence16:30 for depression: A adolescent offspring for a bidirectional relationship systematic review and Ruth Sellers (Cardiff University) Dale Hesdorffer (Columbia meta-analysis University) Ana Jelovac (Trinity College Dublin) [O1.4] [O2.4] [O3.4] Harsh parenting and neural The Association Between Fruit Impact of co-morbid anxiety fear circuitry function in and Vegetable Consumption and/or substance use disorder16:45 high and low anxious and Mental Health Disorders in on outcomes of Psychotherapy youths: Preliminary Canadians for bipolar disorder findings Ian Colman(University of Ottawa) Maree Inder Françoise Maheu (University of Montréal) [O1.5] [O2.5] [O3.5] Change in amygdala and Lessons learned from two Depression and smoking: a hippocampal volumes after Cochrane Reviews on five-year prospective study of twelve weeks of paroxetine depression treatments in patients with major depressive17:00 treatment for major patients with diabetes and disorder depressive disorder patients with coronary artery Isometsä Erkki (University of Henricus G Ruhe (University of disease Helsinki) Amsterdam) Harald Baumeister [O1.6] [O2.6] [O3.6] Modifiable lifestyle factors, Randomized clinical trials Protective factors against depression and underestimate the efficacy of depression during the17:15 inflammation in the Hunter antidepressants in less severe transition from adolescence to Community Study depression adulthood: Findings from a Sarah Hiles Göran Isacsson national Canadian cohort Ian Colman(University of Ottawa) 3
  4. 4. 17:30 – Poster Session19:0019:00 – Welcome Reception20:30Day 2: Thursday, 19th April 201208:30 – SYMPOSIUM 7 SYMPOISUM 8 SYMPOSIUM 910:30 Council Chamber Linacre and Sloane Room Wolfson Theatre Are Specialised Affective Metabolic Depression: A Constitutional Determinants of Disorder Services Useful? Specific Depression Subtype? Anxiety Disorders: Physiological and Session Chair: Chantal Henry Session Chair: Brenda Penninx Neuroimaging Characteristics (University of Paris) (VU University Medical Cente) Session Chair: Hugo Critchley (Brighton and Sussex Medical School) [S7.1] [S8.1] [S9.1]08:30 Canadian Programmes Inflammation, leptin and onset Exaggerated autonomic Sagar Parikh (University of of depression responses and vulnerability to Toronto) anxiety Yuri Milaneschi (National Institutes of Health) Satoshi Umeda (Keio University) [S7.2] [S8.2] [S9.2]09:00 German Algorithm Inflammation, metabolic Early emotional processing Mazda Adli (Charite- syndrome, depression course and bodily arousal universitatsmedizin Berlin) Nicole Vogelzangs (VU University) Henrique Sequeira (Lille University) [S7.3] [S8.3] [S9.3]09:30 French network of bipolar Evidence for differential Interoceptive awareness and expert centres underlying pathophysiology in anxiety Bruno Etain (INSERM, U 955) melancholic versus atypical (Olga Pollatos) depression subtypes Universität Potsdam Femke Lamers (National Institutes Humanwissenschaftliche Fakultät of Health) [S7.4] [S8.4] [S9.4]10:00 ENBREC: European Inflammation and depression Neurobiological pathways Network of Bipolar Expert symptom profile linking socioeconomic position Centres Martin Preisig (University of and health Chantal Henry (University of Lausanne) Peter Gianaros (University of Paris) Pittsburgh)10:30 –11:00 Tea/Coffee Break, Exhibition and Poster Viewing Plenary Session 2 – Wolfson Theatre Chair: Jan Scott (Newcastle University)11:00 – Cognitive Behaviour Therapy in the Treatment and Prevention of Depression12:00 Steve Hollon (Vanderbilt University, Nashville, USA)12:00 –13:30 Lunch Break, Exhibition and Poster Viewing 4
  5. 5. 13:30 – ORAL PRESENTATION ORAL PRESENTATION ORAL PRESENTATION15:30 SESSION 4 SESSION 5 SESSION 6 Council Chamber Linacre and Sloane Room Wolfson Theatre Session Chair: Roger Pinder Session Chair: Allan Young (ISAD Immediate Past (Imperial College London) President) [O4.1] [O5.1] [O6.1] The role of meaning in life Timing of First Exposure to Gender differences in response13:30 in promoting resiliency to Maternal Depression and to terrorist attacks: from late-life suicide ideation Adolescent Emotional Disorder initial response to treatment Marnin J. Heisel (Victoria in a National Canadian Cohort response Hospital) Ian Colman (University of Ottawa) Sara Freedman (Bar Ilan Univ) [O4.2] [O5.2] [O6.2] Age of onset and the Prevention of depression in at- Circadian rhythms in13:45 prospectively observed risk adolescents menopausal depression course of illness in bipolar Judy Garber (Vanderbilt Barbara Parry (University of disorder University) California, San Diego) William Coryell [O4.3] [O5.3] [O6.3] Interaction between Predictors of childrens Lifetime comorbidity of major MTHFR C677T posttraumatic stress and depression and anxiety14:00 Polymorphism and depression after a natural disorders among a community- traumatic childhood events disaster: Gene by environment based sample of women: predicts recurrence in recurrent MDD: a 5,5-year interactions clinical correlates and prospective study Annette La Greca (University of psychosocial features Anja Lok (University of Miami) Jill M. Cyranowski (University of Amsterdam) Pittsburgh Medical Center) [O4.4] [O5.4] [O6.4] P2RX7: Expression Stress and depression in a Trajectories of maternal Responds to Sleep population sample of symptoms of anxiety and14:15 Deprivation and Associates adolescents (TRAILS): the depression over 13 years: with Rapid Cycling in risks and benefits of exposure The influence of stress, social Bipolar Disorder Type 1 to childhood adversities support, and maternal Lena Backlund Albertine Oldehinkel temperament Anni Skipstein (Norwegian Institute of Public Health) [O4.5] [O5.5] [O6.5] Longitudinal hypothalamic- Psychotic symptoms index The BraveHeart project: pituitary-adrenal axis trait ultra-high risk for suicidal randomised controlled trial of14:30 and state effects in behaviour in young people group cognitive behaviour recurrent depression with affective disorders therapy versus brief Roel JT Mocking (University of Amsterdam) Ian Kelleher intervention for depression in cardiac patients Amanda Baker (University of Newcastle, Australia) [O4.6] [O5.6] [O6.6] Suicide and brain chemical Depressive problems and Preventive cognitive therapy14:45 changes with altitude academic performance, social in recurrent depression: a 10 Perry F. Renshaw well-being, and social year follow-up of the DELTA problems in adolescence: study Longitudinal and bidirectional Aart H. Schene (University of effects Amsterdam) Charlotte Verboom 5
  6. 6. [O4.7] [O5.7] [O6.7]15:00 Investigation of reward as Childhood stress-reactivity and A Randomized Controlled Trial a neural biomarker for Inflammatory Mechanisms in of Psychoeducation or depression Major Depressive Disorder Cognitive-Behavioural Therapy Ciara McCabe (Oxford Sarah Cohen-Woods (King’s in Bipolar Disorder: A CANMAT University) College London) Study Sagar Parikh (University of Toronto) [O4.8] [O5.8] [O6.8] Genetic polymorphisms, Identifying clinical risk What makes people persist15:15 hopelessness and suicidal markers for depression in high with internet interventions for risk in a sample of subjects risk offspring depression? with chronic migraine and Becky Mars (Cardiff University) Liesje Donkin affective temperamental dysregulation Gianluca Serafini15:30 –16:00 Tea/Coffee Break, Exhibition and Poster Viewing16:00 –17:30 Poster Session ISAD AGM19:30 Gala Dinner (Ironmonger’s Hall, City of London) 6
  7. 7. Day 3: Friday, 20th April 2012 Plenary Session 3 – Wolfson Theatre08:30 – Chair: Sidney Kennedy (ISAD President)09:30 Epigenetic basis for the transgenerational transmission of individual differences in vulnerability for psychopathology Professor Michael Meaney (McGill University, Montreal, Quebec, Canada)09:30 – SYMPOSIUM 10 SYMPOSIUM 11 SYMPOSIUM 1212:00 Linacre and Sloane Room Wolfson Theatre Council Chamber International Society for Can we Identify those at Risk The Early Identification of Risk Bipolar Disorders: Task of Unipolar and Bipolar for Affective Illness: Findings Force Updates Disorders? from the Orygen Adolescent Development Study Session Chair: Sophia Session Chair: Jan Scott Frangou (King’s College (Newcastle University) Session Chair: Nicholas Allen London) (The University of Melbourne) [S10.1] [S11.1] [S12.1] Womens Task Force: Case finding strategies to Brain development and Physical and Endocrine augment the early adolescent onset depression09:30 Health in Women with identification of bipolar Sarah Whittle (The University of Bipolar Disorder disorders Melbourne) Aysergul Ozerdem (Dokuz Jan Scott (Newcastle University) Eylul University Medical School) [S10.2] [S11.2] [S12.2] Clinical Trials Task Force: Is there any biomarker for Family processes as predictors10:00 Challenges & new bipolarity? of teen depression directions in clinical trials Marion Leboyer (University of Orli Schwartz (The University of design for Bipolar Disorder Paris) Melbourne) Lakshmi Yatham (The University of British Columbia)10:30 – Tea/Coffee Break, Exhibition and Poster Viewing11:00 [S10.3] [S11.3] [S12.3] Neuroimaging Task Force: Neuroendocrine and other Depressive symptoms and11:00 Neural Correlates of predictors of depression C-reactive protein in Bipolar Disorder: What Ian Hickie (University of Sydney) adolescents: Effects of sex have we learned so far? Michelle Byrne (The University of Melbourne) Sophia Frangou (King’s College London) [S10.4] [S11.4] [S12.4] Biomarkers for patients Lifestyle as a risk factor for Affective Psychophysiology11:30 with Bipolar Disorder: depression; A neglected and integration. ISBD Taskforce Perspective opportunity for prevention? Nicholas Allen (The University of Trevor Young (University of Michael Berk (Universities of Melbourne) Toronto) Melbourne & Deakin)12:00 Close of MeetingPlease note that speakers and presentation titles are subject to change at short notice 7